O-GlcNAcylation modulates expression and abundance of N-glycosylation machinery in an inherited glycosylation disorder
Cell Reports · 2024
DOI: 10.1016/j.celrep.2024.114976 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Courtney Matheny-Rabun und 10 weiteren Autor:innen. Beteiligte Einrichtung: JC Self Research Institute, Greenwood Genetic Center, Greenwood, SC 29646, USA. Hauptthemen laut MEDLINE: Zebrafish, Congenital Disorders of Glycosylation, Phosphotransferases (Phosphomutases). Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NINDS NIH HHS, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Core components of the N-glycosylation pathway are known, but the metabolic and post-translational mechanisms regulating this pathway in normal and disease states remain elusive. Using a multi-omic approach in zebrafish, we discovered a mechanism whereby O-GlcNAcylation directly impacts the expression and abundance of two rate-limiting proteins in the N-linked glycosylation pathway. We show in a model of an inherited glycosylation disorder PMM2-CDG, congenital disorders of glycosylation that phosphomannomutase deficiency is associated with increased levels of UDP-GlcNAc and protein O-GlcNAcylation. O-GlcNAc modification increases the transcript and protein abundance of both NgBR and Dpagt1 in pmm2m/m mutants. Modulating O-GlcNAc levels, NgBR abundance, or Dpagt1 activity exacerbated the cartilage phenotypes in pmm2 mutants, suggesting that O-GlcNAc-mediated increases in the N-glycosylation machinery are protective. These findings highlight nucleotide-sugar donors as metabolic sensors that regulate two spatially separated glycosylation pathways, demonstrating how their coordination is relevant to disease severity in the most common congenital disorder of glycosylation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- JC Self Research Institute, Greenwood Genetic Center, Greenwood, SC 29646, USA.
- Department of Clinical Genomics, Mayo Clinic, Rochester, MN 55905, USA.
- Department of Pharmacology and Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.
- Laboratory of Applied Mass Spectrometry, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium; Metabolomics Core Facility Leuven, Center for Cancer Biology, VIB, Leuven, Belgium.
- JC Self Research Institute, Greenwood Genetic Center, Greenwood, SC 29646, USA. Electronic address: heatherfs@ggc.org.
Förderung
- NIGMS NIH HHS
- NINDS NIH HHS
- National Center for Advancing Translational Sciences
- National Institute of General Medical Sciences
- Rare Diseases Clinical Research Network
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Matheny-Rabun, C., Mokashi, S. S., Radenkovic, S., Wiggins, K., Dukes-Rimsky, L., Angel, P., Ghesquiere, B., Kozicz, T., Steet, R., Morava, E., & Flanagan-Steet, H. (2024). O-GlcNAcylation modulates expression and abundance of N-glycosylation machinery in an inherited glycosylation disorder. Cell Reports. https://doi.org/10.1016/j.celrep.2024.114976
Vancouver
Matheny-Rabun C, Mokashi SS, Radenkovic S, Wiggins K, Dukes-Rimsky L, Angel P, et al. O-GlcNAcylation modulates expression and abundance of N-glycosylation machinery in an inherited glycosylation disorder. Cell Reports. 2024. doi:10.1016/j.celrep.2024.114976
BibTeX
@article{MathenyRabun2024,
author = {Matheny-Rabun, Courtney and Mokashi, Sneha S and Radenkovic, Silvia and Wiggins, Kali and Dukes-Rimsky, Lynn and Angel, Peggi and Ghesquiere, Bart and Kozicz, Tamas and Steet, Richard and Morava, Eva and Flanagan-Steet, Heather},
title = {O-GlcNAcylation modulates expression and abundance of N-glycosylation machinery in an inherited glycosylation disorder},
journal = {Cell Reports},
year = {2024},
doi = {10.1016/j.celrep.2024.114976}
}
EUVIMED